Letters Statins and risk of new diabetes

Unanswered questions about higher potency statins and the risk of new diabetes

BMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g4876 (Published 30 July 2014) Cite this as: BMJ 2014;349:g4876
  1. J J Brugts, cardiologist1
  1. 1Department of Cardiogy, Erasmus MC Thoraxcenter, Rotterdam, Netherlands
  1. j.brugts{at}erasmusmc.nl

Dormuth and colleagues conclude that the use of higher potency statins is associated with a moderate increase in new onset diabetes compared with lower potency drugs.1

I have several comments on this article.

Firstly, the authors categorised simvastatin 40 mg as a higher potency statin. This is one of the most commonly prescribed statins and in my opinion not one …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe